Shanghai De Novo Pharmatech Co., Ltd is a new drug discovery company focused on the research and development of novel small molecular drugs on the unmet diseases. The company was established in 2010, and located in Zhangjiang High-Tech Park, Pudong New Area Shanghai. With the help of the unique development environment and combined with the self advantages in pharmaceutical chemistry, analysis, formulation, biology, clinic and other aspects, the company is committed to the research and development of novel small molecular drugs.

At present, there are nearly ten new molecular targeted drug and immuno-oncology drug candidates at different stages of development, the therapeutic areas including: cancer, anti-infective and metabolic disease.